About Ocimum Labs
Ocimum Labs is a Healthcare company based in Hyderabad (India) founded in 2018. A pharmaceutical company supplying intermediates and active ingredients to global firms. It operates on a B2B model. The company has 113 employees. Its Indian entity Ocimum Labs Private Limited reported revenue of ₹45.32 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Intermediates and Active Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Ocimum Labs a pharmaceutical company supplying intermediates and active ingredients to global firms through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and intermediates and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Hyderabad, India
- Employees 113
- SectorsHealthcare
- Website ocimumlabs.com
- Legal Name Ocimum Labs Private Limited
- Date of Incorporation 04 Jul, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹45.32 Cr
FY 2023 · +134% YoY
- Net Profit₹51.6 Lakh
FY 2023 · 1% margin
- EBITDA₹4.66 Cr
FY 2023 · 10% margin
- Employee Count113
Associated legal entities of Ocimum Labs
Ocimum Labs operates through Ocimum Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ocimum Labs Private Limited CIN U24304TG2018PTC125461 | Active | 04 Jul 2018 | Hyderabad, Telangana | ₹45.3 Cr | 113 | 7 | View details |
Board of directors of Ocimum Labs Private Limited (Ocimum Labs)
Ocimum Labs Private Limited is the primary company behind Ocimum Labs. The board of Ocimum Labs Private Limited currently have 5 directors; the longest-serving is Ramachandra Murthy Mandala, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramachandra Murthy Mandala DIN 08173051 | Director | 04 Jul 2018 | 8 yrs 3 mo | Ocimum Labs Private Limited |
| Hari Krishna Mudduluru DIN 08173050 | Director | 04 Jul 2018 | 8 yrs 3 mo | Ocimum Labs Private Limited |
| Rani Aleti DIN 08225202 | Director | 17 Sep 2018 | 8 yrs 1 mo | Ocimum Labs Private Limited |
| Jannu Chiranjivi Bharath DIN 08411131 | Director | 04 Apr 2019 | 7 yrs 6 mo | Ocimum Labs Private Limited |
| Anil Dubba DIN 08321230 | Company Secretary | 25 Oct 2025 | 1 yr | Ocimum Labs Private Limited |
Financials of Ocimum Labs
Figures of Ocimum Labs Private Limited, the primary company behind Ocimum Labs, for FY 2023. Revenue was ₹45.32 Cr (+134% year on year). Net profit was ₹51.6 Lakh (1% margin). EBITDA was ₹4.66 Cr (10% margin). Revenue has grown at a compounded annual rate of +80% over three years.
- ₹45.32 CrRevenue · FY 2023 · +134% YoY
- ₹51.6 LakhNet profit · 1% margin
- ₹4.66 CrEBITDA · 10% margin
- ₹14.31 CrPaid-up capital
- 113Employees (provident fund records)
- +80%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Ocimum Labs Private Limited are on its company page.
Detailed financial statements for Ocimum Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Ocimum Labs
Ocimum Labs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Ocimum Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ocimum Labs
Ocimum Labs was founded in 2018.
Ocimum Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ocimum Labs has 113 employees.
The primary company behind Ocimum Labs, Ocimum Labs Private Limited, reported revenue of ₹45.32 Cr for FY 2023, up 134% year on year.
Ocimum Labs a pharmaceutical company supplying intermediates and active ingredients to global firms through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and intermediates and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Ocimum Labs's top competitors include Laurus Labs, Symbiotec and SeQuent.
Ocimum Labs operates through Ocimum Labs Private Limited.
The legal entities of Ocimum Labs currently have 7 directors, including Rani Aleti, Anil Dubba, Jannu Chiranjivi Bharath and others.